Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 890-898

  Dorr, Adrienne E ^a   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AUTORECEPTOR; CLONIDINE; IDAZOXAN; LYSERGIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; IN VIVO STUDY; LOCUS CERULEUS; LONG TERM CARE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SEROTONINERGIC SYSTEM; SHORT COURSE THERAPY; VAGUS NERVE STIMULATION;

ADRENERGIC ALPHA-AGONISTS; ANESTHESIA; ANIMALS; AUTORECEPTORS; CELL COUNT; CLONIDINE; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; EXTRACELLULAR SPACE; GANGLIA, SPINAL; KINETICS; LOCUS COERULEUS; LYSERGIC ACID DIETHYLAMIDE; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN; SEROTONIN AGONISTS; SYNAPTIC TRANSMISSION; VAGUS NERVE;

EID: 33745947013     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104166     Document Type: Article

References (40)

1. Aghajanian GK (1978) Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. Essays Neurochem Neuropharmacol 3:1-32.
2. Aghajanian GK, Foote WE, and Sheard MH (1968) Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science (Wash DC) 161:706-708.
3. 1A antagonists. Trends Neurosci 19:378-383.
4. Baraban JM and Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363.
5. Barraco IRA (1994) Nucleus of the Solitary Tract. CRC Press, Inc., Boca Raton, FL.
6. Blier P (2003) The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol 13:57-66.
7. Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, and Price LH (2004) Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine and γ-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 56:418-426.
8. Cedarbaum JM and Aghajanian GK (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 178:1-16.
9. Delgado PL and Moreno FA (2000) Role of norepinephrine in depression J Clin Psychiatry 61 (Suppl 1):5-12.
10. Foley JO and DuBois F (1937) Quantitative studies of the vagus nerve in the cat. I: The ratio of sensory and motor studies. J Comp Neurol 67:49-67.
11. Grant MM and Weiss JM (2001) Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biol Psychiatry 49:117-129.
12. Groves DA, Bowman EM, and Brown VJ (2005) Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 379:174-179.
13. Groves DA and Brown VJ (2005) Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 29:493-500.
14. Haddjeri N, Blier P, and de Montigny C (1995) Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Int Clin Psychopharmacol 10 (Suppl 4):11-17.
15. Haddjeri N and Blier P (2000) Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons. Neuroreport 11:1323-1327.
16. Hajos M, Richards CD, Szekely AD, and Sharp T (1998) An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87:95-108.
17. Handforth A and Krahl SE (2001) Suppression of harmaline-induced tremor in rats by vagus nerve stimulation. Mov Disord 16:84-88.
18. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, and Labar DR (2000) A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 1:93-99.
19. Hassert DL, Miyashita T, and Williams CL (2004) The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav Neurosci 118:79-88.
20. B receptor-mediated inhibition of serotonergic neurons. Eur J Pharmacol 143:195-204.
21. Invernizzi RW and Garattini S (2004) Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 28:819-827.
22. Krahl SE, Clark KB, Smith DC, and Browning RA (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39:709-714.
23. Krahl SE, Senanayake SS, Pekary AE, and Sattin A (2004) Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res 38:237-240.
24. Leger L and Descarries L (1978) Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study. Brain Res 145:1-13.
25. Levitt P, Rakic P, and Goldman-Rakic P (1984) Region-specific distribution of catecholamine afferents in primate cerebral cortex: a fluorescence histochemical analysis. J Comp Neurol 227:23-36.
26. Massana J, Moller HJ, Burrows GD, and Montenegro RM (1999) Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder. Int Clin Psychopharmacol 14:73-80.
27. Millan MJ (2004) The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur J Pharmacol 500:371-384.
28. Mongeau R, Blier P, and de Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23:145-195.
29. Montgomery S, Ferguson JM, and Schwartz GE (2003) The antidepressant efficacy of reboxetine in patients with severe depression. J Clin Psychopharmacol 23:45-50.
30. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, and George MS (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66:1097-1104.
31. 2-Adrenoreceptors and depression. J Psychopharm 10:35-42.
32. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed, Academic Press, New York.
33. o proteins in dorsal raphe nucleus. Eur J Pharmacol 265:103-106.
34. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Gilder C, Haines S, et al. (2001) Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects and predictors of outcome. Neuropsychopharmacology 25:713-728.
35. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, and Heath MJ (2001) Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912-1917.
36. Stahl SM, Entsuah R, and Rudolph RL (2002) Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry 52:1166-1174.
37. Szabo ST and Blier P (2001) Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. Eur J Neurosci 13:2077-2087.
38. 2A receptor antagonism on the firing activity of norepinephrine neurons. J Pharmacol Exp Ther 302:983-991.
39. Szabo ST, de Montigny C, and Blier P (2000) Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. Int J Neuropsychopharmacol 3:1-11.
40. Van Bockstaele EJ, Peoples J, and Telegan P (1999) Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J Comp Neurol 412:410-428.